Shanghai, China

Guilong Li

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Guilong Li

Introduction

Guilong Li is a prominent inventor based in Shanghai, China. He has made significant strides in the field of stem cell research, particularly in the treatment of hematopoietic damage. His work has the potential to impact the medical community and improve patient outcomes.

Latest Patents

Guilong Li holds a patent for the "Use of stem cells produced by stem cell generator in treatment of hematopoietic damage." This patent discloses a stem cell generator designed for the generation of organoids after the development of biological materials loaded with active substances. These substances include mesenchymal stem cells, bone morphogenetic proteins, and other growth factors that can induce bone regeneration. The stem cell generator is equipped with various types of blood cells and hematopoietic progenitor/stem cells, which are essential for treating conditions such as bone marrow failure and leukemia caused by radiotherapy or chemotherapy.

Career Highlights

Guilong Li is affiliated with the East China University of Science and Technology, where he contributes to research and development in the field of stem cell technology. His innovative approach to stem cell generation and application has garnered attention in the scientific community.

Collaborations

Guilong Li collaborates with notable colleagues, including Changsheng Liu and Kai Dai, who share his passion for advancing stem cell research. Their combined expertise enhances the potential for groundbreaking discoveries in the field.

Conclusion

Guilong Li's contributions to stem cell research and his innovative patent demonstrate his commitment to improving medical treatments for hematopoietic damage. His work continues to inspire advancements in regenerative medicine and offers hope for patients facing serious health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…